Cardiometabolic Health Disparities Amid the COVID-19 Pandemic and Beyond: A Call to Action for Preventive Cardiology
In 2020, COVID-19 was the third leading cause of death in the United States, claiming over 375,000 lives. Earlier this year, the virus’s mortality rate outpaced that of cardiovascular disease and cancer, making it the number one cause of death. While the pandemic environment has thankfully eased and rates of illness, hospitalization, and mortality have significantly […]
Statins and COVID-19: Effects of Treatment on Patient OutcomesÂ
In an attempt to discover efficacious and safe treatments for COVID-19, the scientific community has been repurposing existing medications with proven track records. One of these established medication classes is statins – which have an excellent record as safe and affordable therapies. Ongoing research is examining the broader use of statins in COVID-19 patients with […]
Surge in Overdose-Related EMS Activations During Pandemic
At the beginning of the pandemic, the trends predicted by public health officials forecasted an increase in the proportion of individuals using substances alone, widespread toxification of the drug supply, and markedly reduced access to treatment, all of which could increase the lethality of overdose incidents. In addition, experts warned against the negative implications of […]
